Arax Advisory Partners’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VKTX
Arax Advisory Partners's VKTX Position: Q2 2026 in Review
Arax Advisory Partners opened a new position in Viking Therapeutics (VKTX) in Q2 2026: 66,469 shares worth $2.59M. The stake represents 0.02% of the portfolio and ranks #730 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in VKTX as recently as Q4 2025.
Arax Advisory Partners first reported a position in VKTX in Q2 2024 and has held it in 5 quarters since. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.
- Arax Advisory Partners held 66,469 shares of Viking Therapeutics worth $2.59M as of Q2 2026.
- Viking Therapeutics was a new Arax Advisory Partners position in Q2 2026.
- Viking Therapeutics made up 0.02% of Arax Advisory Partners's portfolio in Q2 2026, its #730 holding.
- Arax Advisory Partners first reported a position in Viking Therapeutics in Q2 2024 and has held it in 5 quarters since.
- 436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.
Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.